• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传联盟注册库与生物样本库:一种由疾病倡导驱动的新型研究解决方案。

Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solution.

作者信息

Terry Sharon F, Horn Elizabeth J, Scott Joan, Terry Patrick F

机构信息

Genetic Alliance, Washington, DC, USA.

Genetic Alliance Registry & BioBank, Washington, DC, USA.

出版信息

Per Med. 2011 Mar;8(2):207-213. doi: 10.2217/pme.11.1.

DOI:10.2217/pme.11.1
PMID:29783403
Abstract

The Genetic Alliance Registry and BioBank was founded in 2003 on the principal that a shared infrastructure would facilitate easy flow of resources and accelerate disease-specific research. Based on the Pseudoxanthoma Elasticum International Registry and BioBank, six disease advocacy organizations came together to identify the best solutions for advocacy organizations to promote and collect biological samples with associated clinical information from their members. This required a flexible system that could accommodate an extensive amount of data and samples, support new avenues of research, yet be adaptable to meet the needs of a variety of organizations, and straightforward to implement and use. After extensive landscape analyses, a cross-disease, infinitely expandable registry and biorepository was established. This article reports on this effort and shares the lessons learned.

摘要

遗传联盟注册库和生物样本库成立于2003年,其理念是共享基础设施将促进资源的顺畅流通并加速针对特定疾病的研究。基于弹性假黄瘤国际注册库和生物样本库,六个疾病倡导组织联合起来,为倡导组织确定最佳解决方案,以促进从其成员那里收集带有相关临床信息的生物样本。这需要一个灵活的系统,该系统能够容纳大量数据和样本,支持新的研究途径,同时能够适应各种组织的需求,并且易于实施和使用。经过广泛的前景分析,建立了一个跨疾病、可无限扩展的注册库和生物样本库。本文报告了这项工作并分享了经验教训。

相似文献

1
Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solution.遗传联盟注册库与生物样本库:一种由疾病倡导驱动的新型研究解决方案。
Per Med. 2011 Mar;8(2):207-213. doi: 10.2217/pme.11.1.
2
Advocacy groups as research organizations: the PXE International example.作为研究机构的倡导团体:以弹力纤维假黄瘤国际组织为例。
Nat Rev Genet. 2007 Feb;8(2):157-64. doi: 10.1038/nrg1991.
3
Landscape analysis of registries and biobanks: a tool for disease advocacy organizations to enhance translational research systems.登记处和生物样本库的景观分析:疾病宣传组织增强转化研究系统的工具。
Biopreserv Biobank. 2010 Jun;8(2):115-7. doi: 10.1089/bio.2010.0007.
4
ABCC6 and Pseudoxanthoma Elasticum: The Face of a Rare Disease from Genetics to Advocacy.ABCC6与弹性假黄瘤:从遗传学至宣传倡导的罕见病全貌
Int J Mol Sci. 2017 Jul 11;18(7):1488. doi: 10.3390/ijms18071488.
5
The melanoma research alliance: the power of patient advocacy to accelerate research and novel therapies.黑色素瘤研究联盟:患者倡导的力量可加速研究和新型疗法的开发。
Cancer Immunol Res. 2013 Dec;1(6):357-61. doi: 10.1158/2326-6066.CIR-13-0172.
6
An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry.罕见病患者与行业支持的注册机构之间的创新合作关系:全球非典型溶血性尿毒症综合征注册机构
Orphanet J Rare Dis. 2016 Nov 21;11(1):154. doi: 10.1186/s13023-016-0537-5.
7
How disease advocacy organizations participate in clinical research: a survey of genetic organizations.疾病倡导组织如何参与临床研究:遗传组织的调查。
Genet Med. 2012 Feb;14(2):223-8. doi: 10.1038/gim.0b013e3182310ba0.
8
Beaumont health system biobank: a multidisciplinary biorepository and translational research facility.博蒙特健康系统生物样本库:一个多学科生物样本库及转化研究设施。
Biopreserv Biobank. 2013 Aug;11(4):221-8. doi: 10.1089/bio.2013.0005. Epub 2013 Aug 6.
9
A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS.生物样本库样本、信息和数据共享的最小数据集:MIABIS。
Biopreserv Biobank. 2012 Aug;10(4):343-8. doi: 10.1089/bio.2012.0003.
10
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.2010 - 2011年美国肌萎缩侧索硬化症的患病率
MMWR Suppl. 2014 Jul 25;63(7):1-14.

引用本文的文献

1
Advancing rare disease measurement through the Rare Disease Clinical Outcome Assessment Consortium.通过罕见病临床结局评估联盟推进罕见病测量。
Ther Adv Rare Dis. 2024 Dec 16;5:26330040241307962. doi: 10.1177/26330040241307962. eCollection 2024 Jan-Dec.
2
A clinician's guide to omics resources in dermatology.皮肤科组学资源临床医生指南。
Clin Exp Dermatol. 2022 May;47(5):858-866. doi: 10.1111/ced.15117. Epub 2022 Mar 3.
3
Improving Community Advisory Board Engagement in Precision Medicine Research to Reduce Health Disparities.
提高社区咨询委员会在精准医学研究中的参与度以减少健康差距。
J Health Dispar Res Pract. 2019 Winter;12(6):80-94.
4
Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations.在非洲建立多国镰状细胞病登记处:伦理考量
Front Genet. 2019 Oct 10;10:943. doi: 10.3389/fgene.2019.00943. eCollection 2019.
5
Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.发挥我们在生物样本库中的潜力:疾病倡导组织助力转化研究蓬勃发展。
Biopreserv Biobank. 2016 Aug;14(4):314-8. doi: 10.1089/bio.2015.0053. Epub 2016 Apr 8.
6
The involvement of patient organisations in rare disease research: a mixed methods study in Australia.患者组织在罕见病研究中的参与情况:澳大利亚的一项混合方法研究
Orphanet J Rare Dis. 2016 Jan 12;11:2. doi: 10.1186/s13023-016-0382-6.
7
ESR Position Paper on Imaging Biobanks.红细胞沉降率(ESR)关于影像生物样本库的立场文件。
Insights Imaging. 2015 Aug;6(4):403-10. doi: 10.1007/s13244-015-0409-x. Epub 2015 May 22.
8
Biobanks and personalized medicine.生物样本库与个性化医疗。
Clin Genet. 2014 Jul;86(1):50-5. doi: 10.1111/cge.12370. Epub 2014 Mar 27.
9
Down syndrome: national conference on patient registries, research databases, and biobanks.唐氏综合征:患者注册中心、研究数据库和生物库国家会议。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):13-22. doi: 10.1016/j.ymgme.2011.07.005. Epub 2011 Jul 13.